Skip to comments.Stem Cell Injection Beats Collagen for Urinary Incontinence (adult autologous stem cells)
Posted on 02/03/2007 6:02:37 PM PST by neverdem
Volume 37, Issue 2, Page 46 doi:10.1016/S0300-7073(07)70107-X
CHICAGO Injection of adult autologous stem cells shows an excellent success rate for the treatment of urinary stress incontinence, compared with collagen injections, Dr. Matthias Schurich said at the annual meeting of the Radiological Society of North America.
In the study of both women and men, 50 (79%) of the 63 patients randomized to transurethral ultrasound-guided injection of adult stem cells were completely continent after follow-up lasting 630 months, compared with only 2 (7%) of the 28 patients treated with endoscopic injection of collagen after 612 months, he reported on behalf of principal investigator Dr. Ferdinand Frauscher and his colleagues at the Medical University Innsbruck (Austria).
The long follow-up period for the stem cell injections is noteworthy because endoscopic collagen injections work well initially, but the effect is known to wear off relatively quickly, Dr. Schurich said.
The success rate for stem cell injections was better for women than for men, with 39 (93%) of 42 women continent and 11 (52%) of 21 men continent at follow-up. This could be because most of the men had undergone radical prostatectomy with resulting scarring and little or no sphincter muscle remaining to be bulked up by the stem cells, explained Dr. Schurich, also with the university.
The autologous stem cells were obtained from skeletal muscle biopsies of the patient's arm and were cultured to yield roughly 50 million fibroblasts and 50 million myoblasts. The fibroblasts were injected into the urethral submucosa, whereas the myoblasts were implanted into the rhabdosphincter.
Overall, the 63 patients (aged 3684 years) were treated with autologous stem cells between September 2002 and February 2005. During the same period, 21 women and 7 men (aged 3184 years) also diagnosed with urinary stress incontinence were treated with standard transurethral endoscopic injections of collagen. Patients were randomly assigned to the groups according to capacity in the cell culture laboratory.
Compared with baseline, the stem cell-treated patients demonstrated significant improvements in incontinence scores (5.95 vs. 0.44), thickness of the urethra (3.75 mm vs. 5.3 mm) and rhabdosphincter (2.10 mm vs. 3.30 mm), contractility of the rhabdosphincter (0.56 mm vs. 1.46 mm), and quality-of-life scores (51.3 vs. 104.0) at follow-up. In addition to the 50 patients whose incontinence was cured, 6 had substantial improvement in symptoms and 7 experienced no improvement.
Incontinence scores and quality-of-life scores improved significantly among collagen-treated patients, but the improvements were clinically irrelevant for the majority of patients, Dr. Schurich said.
Urethral ultrasound shows thinning of the rhabdosphincter (S) with atrophy (A).
After injection of stem cells, the sphincter appears hyperechoic (S). Photos courtesy Dr. Ferdinand Frauscher
FReepmail me if you want on or off my health and science ping list.
Thanks for the ping.
After having 7 kids, I'm afraid to sneeze!
I didn't want to have to undergo major surgery to fix it.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.